1. Home
  2. FPH vs DCTH Comparison

FPH vs DCTH Comparison

Compare FPH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

N/A

Current Price

$5.16

Market Cap

383.2M

Sector

Finance

ML Signal

N/A

DCTH

Delcath Systems Inc.

HOLD

Current Price

$16.75

Market Cap

578.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPH
DCTH
Founded
2009
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.2M
578.4M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
FPH
DCTH
Price
$5.16
$16.75
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
179.5K
719.1K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
0.04
Revenue
$110,020,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$11.40
$428.50
Revenue Growth
N/A
N/A
52 Week Low
$4.60
$8.12
52 Week High
$6.64
$17.42

Technical Indicators

Market Signals
Indicator
FPH
DCTH
Relative Strength Index (RSI) 49.95 64.12
Support Level $4.89 $10.16
Resistance Level $5.37 $17.42
Average True Range (ATR) 0.13 0.82
MACD -0.01 0.06
Stochastic Oscillator 30.65 86.97

Price Performance

Historical Comparison
FPH
DCTH

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: